The Estee Lauder Companies to partner with biotech firm Serpin Pharma
The Estee Lauder Companies has announced a collaboration with biotech firm, Serping Pharma. The partners hope to explore how anti-inflammatory research can be applied to cosmetics to deliver skin care longevity benefits to consumers. The post The Estee Lauder Companies to partner with biotech firm Serpin Pharma appeared first on Global Cosmetics News.
THE WHAT? The Estee Lauder Companies has announced a collaboration with biotech firm, Serping Pharma. The partners hope to explore how anti-inflammatory research can be applied to cosmetics to deliver skin care longevity benefits to consumers.
THE DETAILS The partnership will accelerate Lauder’s focus on transformative product innovation, drawing on Serpin’s work on Serine Protease Inhibitors and the US prestige beauty giant’s experience in commercializing breakthrough innovations.
THE WHY? Carl Haney, Executive Vice President, Global Innovation and Research and Development (R&D), The Estée Lauder Companies, reveals, “This novel technology will advance our transformative innovation agenda by pushing the boundaries of breakthrough scientific discovery. In partnership with Serpin Pharma, we’re exploring powerful new biological pathways and cutting-edge biotech ingredients to rapidly mitigate visible skin irritation and sensitivity for our prestige beauty consumers worldwide.”
The post The Estee Lauder Companies to partner with biotech firm Serpin Pharma appeared first on Global Cosmetics News.
